ClinicalTrials.Veeva

Menu

ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill ((Greenpep))

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Unknown

Conditions

Critically Ill Patients

Treatments

Procedure: Observational

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT01317381
Version 2.0. 08.12.2

Details and patient eligibility

About

ICG- Leberfunktionstest versus "neue" Biomarker als prognostischer Marker bei intensivmedizischen Patienten

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria: Gruppe 1:

  • Intensiv-Patienten mit Verbrennungen > 10% der Körperoberfläche
  • Alter > 18

Gruppe 2:

  • Intensivpatienten nach grossen chirurgischen Eingriffen
  • Alter > 18

Gruppe 3:

  • Polytraumatisierte, intensivpflichtige Patienten
  • Alter > 18

Exclusion criteria: • Alter < 18

  • Schwangerschaft
  • Einschluss in eine andere Studie
  • Moribunde Patienten
  • Patienten, die kein Deutsch verstehen
  • Jodunverträglichkeit

Trial design

100 participants in 1 patient group

ICU patients
Description:
Admitted patients to the ICU
Treatment:
Procedure: Observational

Trial contacts and locations

1

Loading...

Central trial contact

01 Studienregister MasterAdmins

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems